The launch of the Catalyst®
Pancreatic Lipase Test demonstrates IDEXX's Technology for Life
strategy and will provide veterinarians with quantitative results
at the point-of-care in less than 10 minutes
WESTBROOK, Maine, June 4, 2024
/CNW/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global
leader in pet healthcare innovation, announces the launch of the
Catalyst® Pancreatic Lipase Test, a single-slide
solution for canine and feline patients suspected of pancreatitis.
With the innovative load-and-go workflow of the Catalyst analyzers,
the test can run effortlessly alongside chemistry profiles, leading
to a faster path to diagnosis and enhanced patient outcomes. The
Catalyst Pancreatic Lipase Test will be available in the U.S. and
Canada this September, with a
global rollout to the over 70,000 Catalyst installed base planned
to begin in the fourth quarter of 2024.
Pancreatitis is a common disease among cats and dogs, and while
treatable, it can prove fatal if not caught early. Diagnosing
pancreatitis can be difficult due to its nonspecific symptoms and
subtle clinical signs, including vomiting and weight loss, which
are among the 10 most frequently recorded clinical signs in primary
care clinics.1 Now, with the Catalyst Pancreatic Lipase
Test, veterinarians can receive quantitative results in under 10
minutes. By delivering quantitative diagnostic insights during the
patient visit, the new test empowers veterinarians to confidently
confirm or rule out pancreatitis and immediately begin treatment,
saving crucial time and improving patient outcomes.
"The Catalyst Pancreatic Lipase Test marks the tenth menu
addition launched for the Catalyst platform since 2012, reinforcing
our commitment to extend the clinical value and diagnostic
capabilities of our technologies," said Jay
Mazelsky, President and Chief Executive Officer of IDEXX.
"We are pleased to deliver a highly requested test, which will
streamline the diagnostic workflow and equip veterinarians with the
necessary clinical insights for prompt action."
The Catalyst Pancreatic Lipase Test, coupled with
VetConnect® PLUS software, provides a critical solution
for the long-term management of pancreatitis patients due to the
chronic nature of the disease. VetConnect PLUS allows for seamless
integration of historical data and test results, enabling efficient
patient progress evaluation and treatment response.
"The Catalyst Pancreatic Lipase Test is the first test to use
dry chemistry slide technology that specifically measures
pancreatic lipase and correlates with the IDEXX Reference
Laboratories Spec cPL® and Spec fPL® tests*
to provide the most accurate, quantitative results patient-side for
dogs and cats," said Jörg M. Steiner, Dr.med.vet., PhD, DACVIM-SA,
DECVIM-CA, AGAF, Texas A&M
University.†
New Catalyst SmartQC Control
In the fourth quarter of
2024, the Catalyst platform will be further enhanced with the
launch of the Catalyst® SmartQC® Control, a
load-and-go quality control testing system that is 90% faster than
current methods.2 The Catalyst SmartQC Control offers an
intuitive workflow that takes less than 15 minutes, ensuring
quality control is run consistently without compromising staff
productivity. These enhancements will be delivered through IDEXX
SmartService™ Solutions, a cloud-based software that supports
in-house instruments and powers seamless upgrades for new tests and
features.
Please visit idexx.com for more information on the Catalyst
Pancreatic Lipase Test and Catalyst SmartQC Control.
About IDEXX
IDEXX is a global leader in pet healthcare
innovation. Our diagnostic and software products and services
create clarity in the complex, constantly evolving world of
veterinary medicine. We support longer, fuller lives for pets by
delivering insights and solutions that help the veterinary
community around the world make confident decisions—to advance
medical care, improve efficiency, and build thriving practices. Our
innovations also help ensure the safety of milk and water across
the world and maintain the health and well-being of people and
livestock. IDEXX Laboratories, Inc. is a member of the S&P 500®
Index. Headquartered in Maine,
IDEXX employs approximately 11,000 people and offers solutions and
products to customers in more than 175 countries and territories.
For more information about IDEXX, visit: www.idexx.com.
Note Regarding Forward-Looking Statements
This news
release contains or may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Forward-looking statements can be identified by the use of
words such as "expects," "may," "anticipates," "intends," "would,"
"will," "plans," "believes," "estimates," "should," "project," and
similar words and expressions. These forward-looking statements are
intended to provide our current expectations or forecasts of future
events; are based on current estimates, projections, beliefs, and
assumptions; and are not guarantees of future performance. Actual
events or results may differ materially from those described in the
forward-looking statements. These statements are subject to risks,
uncertainties, assumptions, and other important factors. Readers
are cautioned not to put undue reliance on such forward-looking
statements because actual results may vary materially from those
expressed or implied. The reports filed by IDEXX pursuant to
United States securities laws
contain discussions of some of these risks and uncertainties. IDEXX
assumes no obligation to, and expressly disclaims any obligation
to, update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise. Readers are
advised to review IDEXX's filings with the United States
Securities and Exchange Commission (which are available from the
SEC's EDGAR database at sec.gov and via IDEXX's website at
idexx.com).
1Robinson NJ, Dean RS, Cobb M, Brennan ML.
Investigating common clinical presentations in first opinion small
animal consultations using direct observation. Vet Rec.
2015;176(18):463. doi:10.1136/vr.102751
*The Spec cPL Test for dogs and the Spec fPL Test for cats measure
the level of pancreas-specific lipase in the blood:
www.idexx.com/en/veterinary/reference-laboratories/pancreatic-health.
†Dr. Steiner has received compensation from time to time
for consulting services he has provided to IDEXX.
2Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/idexx-expands-test-menu-for-the-catalyst-platform-to-support-veterinarians-globally-in-diagnosing-pancreatitis-302162411.html
SOURCE IDEXX Laboratories, Inc.